首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1486830

全球人造血管市場-市場分析、競爭格局、市場預測（2030年）

Artificial blood vessels - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年05月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2023 年全球血管移植市場規模為 21.9 億美元，預計到 2030 年將達到 30.7 億美元，2024-2030 年預測期間複合年增長率為 5.02%。對血管移植物的需求主要是由老年人口的快速增長和各種心血管疾病盛行率的上升所推動的。此外，由於技術進步、該領域正在進行的大量研究活動、醫療保健提供者、研究人員和行業參與者之間的聯盟和戰略夥伴關係，預計該市場將成長，預計從2024 年到2030 年將成長。

人造血管市場動態

心血管疾病在世界範圍內非常普遍，其中冠狀動脈疾病和周圍血管疾病所佔比例最大。例如，根據美國心臟協會（2022）的數據，2020 年全球約有 2.441 億人患有冠狀動脈心臟病（缺血性心臟病）。同一份文件顯示，2020年北非、中東、中亞、南亞和東歐是全球冠心病患病率最高的地區。

根據英國心臟基金會 2022 年的數據，2019 年全球約有 5.5 億人（每 14 人中就有 1 人）患有心臟和循環系統疾病。據同一消息來源稱，2019年，北美有4,103,135人患有心血管疾病，1,089,947人被診斷患有冠狀動脈疾病，498,551人患有中風，而在亞洲，有32,376,834人患有心血管疾病。患有冠狀動脈疾病，8,111,044人中風。

上述文件進一步指出，冠狀動脈心臟病（缺血性）心臟病、週邊動脈（血管）疾病、中風和心房顫動仍是2019年全球最常見且流行的心血管疾病。

血管狹窄、閉塞或嚴重功能障礙是心血管疾病的多種病理生理機轉之一。主動脈特別容易受到各種病變的影響，例如腹主動脈瘤、主動脈梗塞和慢性血液透析通路。

血管置換涉及使用人造血管，是治療閉塞血管結構的首選手術選擇。由於健康自體血管的供應有限以及術後併發症的發生率，對血管移植物的需求也在增加。

同樣，與新型人造血管開發相關的持續研究活動預計將在短期內加速市場成長。例如，2022 年 9 月，南丹麥大學 (SDU) 和歐登塞大學醫院 (OUH) 的研究人員正在致力於開發一種革命性的人造血管，以防止阻塞和感染。

然而，製造和開發血管移植物面臨的課題，以及與血管移植物相關的監管合規性和其他安全問題，可能會限制血管移植物市場的整體成長。

人工血管市場區隔分析

在血管移植市場的應用領域，週邊動脈疾病類別預計將在 2023 年獲得可觀的收入佔有率。這可能是由於週邊動脈疾病的盛行率增加所致。

例如，根據加拿大統計局的最新研究，PAD 在加拿大廣泛流行，每年影響約 80 萬加拿大人。

此外，與週邊動脈疾病相關的年齡、吸菸和高血壓等危險因子的增加也進一步推動了血管移植市場的成長。

根據2021年加拿大人口普查，2021年85歲以上的人口數量超過861,000人。文件也指出，從2016年到2021年，85歲及以上的人口數將增加12%，是加拿大總人口成長的兩倍多。

本報告研究和分析了全球血管移植市場，提供市場規模和預測、驅動因素和課題、公司和產品概況等。

Artificial Blood Vessels Market By Polymer Type (Polydioxanone, Elastomer, Polyethylene Terephthalate, And Others), Application (Aortic Disease, Peripheral Artery Disease, And Hemodialysis), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the prevalence of cardiovascular diseases (CVDS) and increasing research and development activities

The global artificial blood vessels market was valued at USD 2.19 billion in 2023, growing at a CAGR of 5.02% during the forecast period from 2024 to 2030 to reach USD 3.07 billion by 2030. The demand for artificial blood vessels is primarily being boosted by the rising prevalence of various cardiovascular diseases coupled with a rapidly growing geriatric population. Furthermore, the artificial blood vessels market is anticipated to grow on account of the growing technological advancement, a large number of ongoing research activities in this field, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute in the overall growth of the artificial blood vessels market during the forecast period from 2024-2030.

Artificial Blood Vessels Market Dynamics:

Cardiovascular diseases are highly prevalent across the globe, of which the largest proportion is taken by coronary and peripheral vascular diseases. For instance, according to the American Heart Association 2022, globally, about 244.1 million people were living with coronary (ischemic) heart disease in 2020. As per the same source, North Africa, the Middle East, Central and South Asia, and Eastern Europe had the highest prevalence rates of coronary (ischemic) heart disease in the world in 2020.

As per the data provided by British Heart Foundation 2022, worldwide around 550 million which stands for 1 in 14 people were living with heart and circulatory diseases in 2019 and this includes about 290 million women and around 260 million men. As per the same source, in 2019, in North America, cardiovascular diseases affected 4,103,135 people, 1,089,947 people were diagnosed with coronary artery disease, and 498,551 suffered from stroke; In Asia, there were 32,376,834 people diagnosed with cardiovascular diseases, from which 12,543,833 individuals were affected by coronary artery disease, and 8,111,044 population was suffered from a stroke.

The source mentioned above further stated that coronary (ischemic) heart disease (200 million cases), peripheral arterial (vascular) disease (110 million cases), stroke (100 million cases), and atrial fibrillation (60 million cases) remained the commonest and prevalent cardiovascular conditions worldwide in 2019.

Stenosis, occlusion, or severe dysfunction of blood vessels are among various pathophysiological mechanisms of cardiovascular diseases. The aorta tends to be affected by a range of disease conditions including abdominal aortic aneurysm, coarctation of the aorta, and chronic hemodialysis access among others.

For the treatment of obstructed vascular structures, vascular replacement involving the usage of artificial blood vessels is the preferred surgical option. The demand for artificial blood vessels is also on the rise due to the limited availability of healthy autologous vessels as well as the incidence of postoperative complications.

Similarly, ongoing research activities about the development of novel artificial blood vessels will accelerate market growth in the foreseeable future. For example, in September 2022, University of Southern Denmark (SDU) and Odense University Hospital (OUH) researchers are working on the development of a revolutionary artificial blood vessel that is prevented from closing or becoming infected.

However, regulatory compliance and other safety concerns associated with artificial blood vessels along with challenges encountered during manufacturing and development of artificial blood vessels may restrict the growth of the overall artificial blood vessels market.

Artificial Blood Vessels Market Segment Analysis:

Artificial Blood Vessels Market by Polymer Type (Polydioxanone, Elastomer, Polyethylene Terephthalate, and Others), Application (Aortic Disease, Peripheral Artery Disease, and Hemodialysis), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the artificial blood vessels market, the peripheral artery disease category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the rising prevalence of peripheral artery disease.

For instance, as per the latest study provided by Statistic Canada, PAD is widely prevalent in the country, affecting approximately 800,000 Canadians, every year.

Also, the rise in the number of risk factors such as old age, smoking, hypertension, and others associated with peripheral artery disease is further boosting the market growth for artificial blood vessels.

As per the Canadian Census 2021, over 861,000 people aged 85 and older were counted in 2021. The aforesaid source also stated that, between 2016 and 2021, the number of people aged 85 and older grew by 12%, which is more than twice as high as the growth seen for the overall Canadian population.

According to the facts and figures provided by WHO in 2022, it was estimated that in Spain, almost every fifth of adults and adolescents smoke.

The same source stated that almost 18% of adults smoked tobacco in the year 2020 and 21% of adolescents aged 15-16 smoked cigarettes in 2019. The increasing consumption of tobacco and smoking among adults and youngsters will make them more prone to cardiovascular disorders such as PAD, and others.

By replacing the damaged native blood vessels, artificial blood vessels help to treat severe cases of peripheral artery disease.

Therefore, owing to the above-mentioned factors, the peripheral artery disease category is expected to register significant growth, thereby driving the growth of the overall artificial blood vessels market during the forecast period.

North America Is Expected To Dominate The Overall Artificial Blood Vessels Market:

Among all the regions, North America is estimated to account for the largest share of the Artificial Blood Vessels market in the year 2023. Owing to the significance of key growth factors such as the increased mortality rate due to aortic aneurysm, rise in cases of peripheral artery disease and coronary artery diseases among other cardiovascular disease conditions, growing awareness programs and initiatives related to heart health, high disposable income, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others, the market for artificial blood vessels is expected to witness prosperity in the region during the forecast period 2024-2030.

The Centers for Disease Control and Prevention (CDC) 2021 highlighted that aortic aneurysms or aortic dissections were responsible for causing about 9,904 deaths in 2019 in the United States. As per the same source, 59% of those deaths occurred among men. The number of deaths due to aortic aneurysms could have been avoided with proper surgical treatment via the utilization of artificial blood vessels.

As per the Centers for Disease Control and Prevention 2022, approximately 6.5 million people aged 40 and older were there with peripheral artery disease (PAD) condition in 2021 in the United States.

Another factor contributing to the growth of the artificial blood vessels market is the continued rise in the number of individuals involved in smoking. For instance, as per the Centers for Disease Control and Prevention 2022, approximately 40 million people smoke cigarettes in the US. As per the same source, every day nearly 1,600 US youth aged 18 years or younger smoke their first cigarette. Smoking increases the risk for a range of cardiovascular disease conditions.

Thus, the above-mentioned factors are likely to propel the growth of the artificial blood vessels market in the region during the forecast period from 2024-2030.

Artificial Blood Vessels Market Key Players:

Some of the key market players operating in the Artificial Blood Vessels market include LeMaitre Vascular Inc., Terumo Medical Corporation, W. L. Gore and Associates, B. Braun SE, Roumai Med, Jiangsu Bioda Life Science Co. Ltd., Artivion, Inc., Getinge, Vygon, and others.

Recent Developmental Activities In The Artificial Blood Vessels Market:

In November 2022, Jiangsu Bioda Life Science Co. Ltd.'s artificial blood vessel gained class III medical device approval from China's NMPA, marking the first domestic artificial blood vessel to get such approval. Nantong, China-based Bioda's vessel is used for aortic coarctation and aneurysms.

Key Takeaways From The Artificial Blood Vessels Market Report Study

Market size analysis for current artificial blood vessels market size (2023), and market forecast for 6 years (2024-2030)
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global artificial blood vessels market.
Various opportunities available for the other competitors in the artificial blood vessels market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current artificial blood vessels market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for artificial blood vessel market growth in the coming future?

Target Audience Who Can Be Benefited From This Artificial Blood Vessels Market Report Study

Artificial Blood Vessels product providers
Research organizations and consulting companies
Artificial Blood Vessels -related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in artificial blood vessels
Various End-users who want to know more about the artificial blood vessels market and the latest technological developments in the artificial blood vessels market.

Frequently Asked Questions For The Artificial Blood Vessels Market:

1. What are artificial blood vessels?

Artificial blood vessels are represented as ideal vascular grafts that are composed of viable tissues. They offer advantages including compliance, lack of thrombogenicity, and resistance to infections among others.

2. What is the market for global artificial blood vessels?

The artificial blood vessels market was valued at USD 2.19 billion in 2023, growing at a CAGR of 5.02% during the forecast period from 2024 to 2030 to reach USD 3.07 billion by 2030.

3. What are the drivers for the global artificial blood vessels market?

The demand for artificial blood vessels is primarily being boosted by the increasing patient population suffering from various heart conditions benefits of artificial blood vessels for vascular obstruction, and continuous innovation in product development among others, thereby contributing to the overall growth of the Artificial Blood Vessels market during the forecast period from 2024-2030.

4. Who are the key players operating in the global artificial blood vessels market?

Some of the key market players operating in the artificial blood vessels market include LeMaitre Vascular Inc., Terumo Medical Corporation, W. L. Gore and Associates, B. Braun SE, Roumai Med, Jiangsu Bioda Life Science Co. Ltd., Artivion, Inc., Getinge, Vygon, and others.

5. Which region has the highest share in the artificial blood vessels market?

North America is expected to dominate the overall artificial blood vessels market during the forecast period from 2024-2030. Owing to factors such as the rise in the number of people with cardiovascular diseases, the surge in the number of awareness programs and initiatives for heart health, high disposable income, sophisticated healthcare infrastructure, and high awareness among others, North American artificial blood vessels market is expected to growth in coming years.

1. Artificial Blood Vessels Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Artificial Blood Vessels Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Artificial Blood Vessels Market Key Factors Analysis

5.1. Artificial Blood Vessels Market Drivers
- 5.1.1. The increasing prevalence of cardiovascular diseases (CVDs) coupled with the surge in risk factors such as old age, smoking, and others associated with causing CVDs
- 5.1.2. Technological innovations in product development
- 5.1.3. Collaboration between researchers, healthcare professionals, and industry players
5.2. Artificial Blood Vessels Market Restraints and Challenges
- 5.2.1. Regulatory compliance and other safety concerns associated with artificial blood vessels
- 5.2.2. Challenges encountered during manufacturing and development of artificial blood vessels
5.3. Artificial Blood Vessels Market Opportunities
- 5.3.1. Surge in the number of research activities associated with the development of artificial blood vessels
- 5.3.2. Advances in bioengineering techniques

6. Artificial Blood Vessels Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Artificial Blood Vessels Market Layout

7.1. By Polymer Type
- 7.1.1. Polydioxanone
- 7.1.2. Elastomer
- 7.1.3. Polyethylene Terephthalate
- 7.1.4. Others
7.2. By Application
- 7.2.1. Aortic Disease
- 7.2.2. Peripheral Artery Disease
- 7.2.3. Hemodialysis
7.3. By Geography
- 7.3.1. North America
  - 7.3.1.1. United States Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.1.2. Canada Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.1.3. Mexico Artificial Blood Vessels Market Size in USD million (2021-2030)
- 7.3.2. Europe
  - 7.3.2.1. France Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.2.2. Germany Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.2.3. United Kingdom Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.2.4. Italy Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.2.5. Spain Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.2.6. Rest of Europe Artificial Blood Vessels Market Size in USD million (2021-2030)
- 7.3.3. Asia-Pacific
  - 7.3.3.1. China Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.3.2. Japan Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.3.3. India Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.3.4. Australia Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.3.5. South Korea Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.3.6. Rest of Asia-Pacific Artificial Blood Vessels Market Size in USD million (2021-2030)
- 7.3.4. Rest of the World (RoW)
  - 7.3.4.1. Middle East Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.4.2. Africa Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.4.3. South America Artificial Blood Vessels Market Size in USD million (2021-2030)

8. Artificial Blood Vessels Market Company and Product Profiles

8.1. B. Braun SE
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Terumo Medical Corporation
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Roumai Med
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. Jiangsu Bioda Life Science Co. Ltd
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. W. L. Gore & Associates, Inc.
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. LeMaitre Vascular Inc.
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Artivion, Inc
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Getinge
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Vygon
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy